A metabolomic approach to understanding the metabolic link between obesity and diabetes

Molecules and Cells

Volumn 38, Issue 7, 2015, Pages 587-596

  Park, Seokjae ^a   Sadanala, Krishna Chaitanya ^a   Kim, Eun Kyoung ^a  

^a Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

Author keywords

Biomarkers; Diabetes; Metabolites; Metabolomics; Obesity

Indexed keywords

ACYLCARNITINE; AMINO ACID; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; GLUCOSE; ISOLEUCINE; LEUCINE; LYSOPHOSPHATIDYLCHOLINE; NUCLEOTIDE; SPHINGOMYELIN; VALINE;

AMINO ACID METABOLISM; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISORDER; METABOLOMICS; NONHUMAN; NUCLEOTIDE METABOLISM; OBESITY; REVIEW; XENOBIOTIC METABOLISM; ANIMAL; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM;

ANIMALS; BIOMARKERS; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; OBESITY;

EID: 84949950525     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2015.0126     Document Type: Review

References (123)

1. Abu Bakar, M.H., Sarmidi, M.R., Cheng, K.K., Ali Khan, A., Suan, C.L., Zaman Huri, H., and Yaakob, H. (2015). Metabolomics-the complementary field in systems biology: a review on obesity and type 2 diabetes. Mol. Biosyst. [Epub ahead of print].
2. Adams, S.H. (2011). Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv. Nutr. 2, 445-456.
3. Backman, L., Hallberg, D., and Kallner, A. (1975). Amino acid pattern in plasma before and after jejuno-ileal shunt operation for obesity. Scand J. Gastroenterol. 10, 811-816.
4. Bak, J.F., Moller, N., Schmitz, O., Saaek, A., and Pedersen, O. (1992). In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia 35, 777-784.
5. Bala, L., Ghoshal, U.C., Ghoshal, U., Tripathi, P., Misra, A., Gowda, G.A., and Khetrapal, C.L. (2006). Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy. Magn. Reson. Med. 56, 738-744.
6. Bao, Y., Zhao, T., Wang, X., Qiu, Y., Su, M., and Jia, W. (2009). Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J. Proteome Res. 8, 1623-1630.
7. Barbas, C., Moraes, E.P., and Villaseñor, A. (2011). Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples. J. Pharm. Biomed. Anal. 55, 823-831.
8. Beger, R.D. (2013). A review of applications of metabolomics in cancer. Metabolites 3, 552-574.
9. Bentley-Lewis, R., Xiong, G., Lee, H., Yang, A., Huynh, J., and Kim, C. (2014). Metabolomic analysis reveals amino acid responses to an oral glucose tolerance test in women with prior history of gestational diabetes mellitus. J. Clin. Transl. Endocrinol. 1, 38-43.
10. Berndt, J., Kloting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M.R., Stumvoll, M., and Bluher, M. (2005). Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54, 2911-2916.
11. Blusztajn, J.K. (1998). Choline, a vital amine. Science 281, 794-795.
12. Boling, C.L., Westman, E.C., and Yancy, W.S., Jr. (2009). Carbohydrate-restricted diets for obesity and related diseases: an update. Curr. Atheroscler. Rep. 11, 462-469.
13. Bollard, M.E., Stanley, E.G., Lindon, J.C., Nicholson, J.K., and Holmes, E. (2005). NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18, 143-162.
14. Bray, G.A. (2004). Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89, 2583-2589.
15. Brennan, L., Shine, A., Hewage, C., Malthouse, J.P., Brindle, K.M., McClenaghan, N., Flatt, P.R., and Newsholme, P. (2002). A nuclear magnetic resonance-based demonstration of substantial oxidative L-alanine metabolism and L-alanine-enhanced glucose metabolism in a clonal pancreatic beta-cell line: metabolism of Lalanine is important to the regulation of insulin secretion. Diabetes 51, 1714-1721.
16. Carr, P.W., Stoll, D.R., and Wang, X. (2011). Perspectives on recent advances in the speed of high-performance liquid chromatography. Anal. Chem. 83, 1890-1900.
17. Cha, Y.S. (2008). Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pac. J. Clin. Nutr. 17, 306-308.
18. Chan, J.C., Malik, V., Jia, W., Kadowaki, T., Yajnik, C.S., Yoon, K.H., and Hu, F.B. (2009). Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301, 2129-2140.
19. Charles, S., and Henquin, J.C. (1983). Distinct effects of various amino acids on 45Ca2+ fluxes in rat pancreatic islets. Biochem. J. 214, 899-907.
20. Chen, J., Zhao, X., Fritsche, J., Yin, P., Schmitt-Kopplin, P., Wang, W., Lu, X., Häring, H.U., Schleicher, E.D., Lehmann, R., et al. (2009). Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal. Chem. 80, 1280-1289.
21. Cheng, S., Rhee, E.P., Larson, M.G., Lewis, G.D., McCabe, E.L., Shen, D., Palma, M.J., Roberts, L.D., Dejam, A., Souza, A.L., et al. (2012). Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 125, 2222-2231.
22. Chevalier, S., Marliss, E.B., Morais, J.A., Lamarche, M., andGougeon, R. (2005). Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am. J. Clin. Nutr. 82, 355-365.
23. Cho, Y., Ahmed, A., Islam, A., and Kim, S. (2015). Developments in FT-ICR MS instrumentation, ionization techniques, and data interpretation methods for petroleomics. Mass Spectrom. Rev. 34, 248-263.
24. Chylla, R.A., Hu, K., Ellinger, J.J., and Markley, J.L. (2011). Deconvolution of two-dimensional NMR spectra by fast maximum likelihood reconstruction: application to quantitative metabolomics. Anal. Chem. 83, 4871-4880.
25. Courant, F., Royer, A.L., Chereau, S., Morvan, M.L., Monteau, F., Antignac, J.P., and Le Bizec, B. (2012). Implementation of a semi-automated strategy for the annotation of metabolomic fingerprints generated by liquid chromatography-high resolution mass spectrometry from biological samples. Analyst 137, 4958-4967.
26. Despres, J.P., Moorjani, S., Lupien, P.J., Tremblay, A., Nadeau, A., and Bouchard, C. (1992). Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol. Cell Biochem. 113, 151-169.
27. Di Virgilio, F., and Solini, A. (2002). P2 receptors: new potential players in atherosclerosis. Br J. Pharmacol. 135, 831-842.
28. Diao, C., Zhao, L., Guan, M., Zheng, Y., Chen, M., Yang, Y., Lin, L., Chen, W., and Gao, H. (2014). Systemic and characteristic metabolites in the serum of streptozotocin-induced diabetic rats at different stages as revealed by a (1)H-NMR based metabonomic approach. Mol. Biosyst. 10, 686-693.
29. Dixon, G., Nolan, J., McClenaghan, N., Flatt, P.R., and Newsholme, P. (2003). A comparative study of amino acid consumption by rat islet cells and the clonal beta-cell line BRIN-BD11 – the functional significance of L-alanine. J. Endocrinol. 179, 447-454.
30. Drogan, D., Dunn, W.B., Lin, W., Buijsse, B., Schulze, M.B., Langenberg, C., Brown, M., Floegel, A., Dietrich, S., Rolandsson, O., et al. (2015). Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin. Chem. 61, 487-497.
31. Du, F., Virtue, A., Wang, H., and Yang, X.F. (2013). Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomark Res. 1, 17.
32. Dudzinska, W. (2014). Purine nucleotides and their metabolites in patients with type 1 and 2 diabetes mellitus. J. Biomed. Sci. Eng. 7, 38-44.
33. Felig, P., Marliss, E., and Cahill, G.F., Jr. (1969). Plasma amino acid levels and insulin secretion in obesity. N Engl. J. Med. 281, 811-816.
34. Felig, P., Wahren, J., Hendler, R., and Brundin, T. (1974). Splanchnic glucose and amino acid metabolism in obesity. J. Clin. Invest. 53, 582-590.
35. Fiehn, O., Garvey, W.T., Newman, J.W., Lok, K.H., Hoppel, C.L., and Adams, S.H. (2010). Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5, e15234.
36. Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.G., Fritsche, A., Häring, H.U., Hrab_ de Angelis, M., Peters, A., et al. (2013). Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648.
37. Ford, E.S., Williamson, D.F., and Liu, S. (1997). Weight change and diabetes incidence: findings from a national cohort of US adults. Am. J. Epidemiol. 146, 214-222.
38. Franz, M.J. (2008). Medical nutrition therapy for diabetes mellitus and hypoglycemia of nondiabetic origin. In Food, Nutrition and Diet therapy (Canada, Saunders).
39. Freidenberg, G.R., Reichart, D., Olefsky, J.M., and Henry, R.R. (1988). Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J. Clin. Invest. 82, 1398-1406.
40. Friedrich, N. (2012). Metabolomics in diabetes research. Metabolomics in human type 2 diabetes research. J. Endocrinol. 215, 29-42.
41. Gibellini, F., and Smith, T.K. (2010). The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414-428.
42. Goek, O.N., Doring, A., Gieger, C., Heier, M., Koenig, W., Prehn, C., Romisch-Margl, W., Wang-Sattler, R., Illig, T., Suhre, K., et al. (2012). Serum metabolite concentrations and decreased GFR in the general population. Am. J. Kidney Dis. 60, 197-206.
43. Gogna, N., Krishna, M., Oommen, A.M., and Dorai, K. (2015). Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach. Mol. Biosyst. 11, 595-606.
44. Golay, A., Swislocki, A.L., Chen, Y.D., Jaspan, J.B., and Reaven, G.M. (1986). Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J. Clin. Endocrinol. Metab. 63, 481-484.
45. Goodacre, R., Vaidyanathan, S., Dunn, W.B., Harrigan, G.G., and Kell, D.B. (2004). Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22, 245-252.
46. Gougeon, R., Morais, J.A., Chevalier, S., Pereira, S., Lamarche, M., and Marliss, E.B. (2008). Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31, 128-133.
47. Gowda, G.A., Ijare, O.B., Somashekar, B.S., Sharma, A., Kapoor, V.K., and Khetrapal, C.L. (2006). Single-step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy. Lipids 41, 591-603.
48. Griffin, J.L., and Kauppinen, R.A. (2007). Tumour metabolomics in animal models of human cancer. J. Proteome Res. 6, 498-505.
49. Guan, M., Xie, L., Diao, C., Wang, N., Hu, W., Zheng, Y., Jin, L., Yan, Z., and Gao, H. (2013). Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics. PLoS One 8, e60409.
50. Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D., Lallone, R.L., Burley, S.K., and Friedman, J.M. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
51. Haslam, D.W., and James, W.P. (2005). Effect of obesity on the incidence of type 2 diabetes mellitus varies with age among Indian women. Lancet 366, 1197-1209.
52. He, Q., Ren, P., Kong, X., Wu, Y., Wu, G., Li, P., Hao, F., Tang, H., Blachier, F., and Yin, Y. (2012). Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. J. Nutr. Biochem. 23, 133-139.
53. Heilbronn, L.K., Rood, J., Janderova, L., Albu, J.B., Kelley, D.E., Ravussin, E., and Smith, S.R. (2004). Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 89, 1844-1848.
54. Huang, Q., Yin, P., Wang, J., Chen, J., Kong, H., Lu, X., and Xu, G. (2011). Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879, 961-967.
55. Junot, C., Madalinski, G., Tabet, J.C., and Ezan, E. (2010). Fourier transform mass spectrometry for metabolome analysis. Analyst 135, 2203-2219.
56. Kim, J.Y., Park, J.Y., Kim, O.Y., Ham, B.M., Kim, H.J., Kwon, D.Y., Jang, Y., and Lee, J.H. (2010). Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J. Proteome Res. 9, 4368-4375.
57. Kim, H.J., Kim, J.H., Noh, S., Hur, H.J., Sung, M.J., Hwang, J.T., Park, J.H., Yang, H.J., Kim, M.S., Kwon, D.Y., et al. (2011). Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 10, 722-731.
58. Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Furnsinn, C., Promintzer, M., Anderwald, C., et al. (2007). The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56, 1600-1607.
59. Kussmann, M., Raymond, F., and Affolter, M. (2006). OMICSdriven biomarker discovery in nutrition and health. J. Biotechnol. 124, 758-787.
60. Lagarde, M., Géloën, A., Record, M., Vance, D., and Spener, F. (2003). Lipidomics is emerging. Biochim. Biophys. Acta 1634, 61.
61. Lin, L., Yu, Q., Yan, X., Hang, W., Zheng, J., Xing, J., and Huang, B. (2010). Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst 135, 2970-2978.
62. Liu, L., Wang, M., Yang, X., Bi, M., Na, L., Niu, Y., Li, Y., and Sun, C. (2013). Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS. Clin. Chem. 59, 1338-1348.
63. Madsen, R., Lundstedt, T., and Trygg, J. (2010). Chemometrics in metabolomics a review in human disease diagnosis. Anal. Chim. Acta 659, 23-33.
64. Malik, V.S., Popkin, B.M., Bray, G.A., Despres, J.P., and Hu, F.B. (2010). Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121, 1356-1364.
65. Maskarinec, G., Grandinetti, A., Matsuura, G., Sharma, S., Mau, M., Henderson, B.E., and Kolonel, L.N. (2009). Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort. Ethn. Dis. 19, 49-55.
66. Mihalik, S.J., Michaliszyn, S.F., de las Heras, J., Bacha, F., Lee, S., Chace, D.H., DeJesus, V.R., Vockley, J., and Arslanian, S.A. (2012). Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care 35, 605-611.
67. Mooradian, A.D., Haas, M.J., and Wong, N.C. (2004). Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes 53, 513-520.
68. Mooradian, A.D., Haas, M.J., Wehmeier, K.R., and Wong, N.C. (2008). Obesity-related changes in high-density lipoprotein metabolism. Obesity (Silver Spring) 16, 1152-1160.
69. Moore, S., and Stein, W.H. (1954). Procedures for the chromatographic determination of amino acids on four per cent cross-linked sulfonated polystyrene resins. J. Biol. Chem. 211, 893-906.
70. Moore, S.C., Matthews, C.E., Sampson, J.N., Stolzenberg-Solomon, R.Z., Zheng, W., Cai, Q., Tan, Y.T., Chow, W.H., Ji, B.T., Liu, D.K., et al. (2014). Human metabolic correlates of body mass index. Metabolomics 10, 259-269.
71. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311-326.
72. Nikiforova, V.J., Giesbertz, P., Wiemer, J., Bethan, B., Looser, R., Liebenberg, V., Ruiz Noppinger, P., Daniel, H., and Rein, D. (2014). Glyoxylate, a new marker metabolite of type 2 diabetes. J. Diabetes Res. 2014, 685204.
73. Nyenwe, E.A., Jerkins, T.W., Umpierrez, G.E., and Kitabchi, A.E. (2011). Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60, 1-23.
74. Oberbach, A., Bluher, M., Wirth, H., Till, H., Kovacs, P., Kullnick, Y., Schlichting, N., Tomm, J.M., Rolle-Kampczyk, U., Murugaiyan, J., et al. (2011). Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J. Proteome Res. 10, 4769-4788.
75. Oliver, S.G., Winson, M.K., Kell, D.B., and Baganz, F. (1998). Systematic functional analysis of the yeast genome. Trends Biotechnol. 16, 373-378.
76. Oresic, M., Simell, S., Sysi-Aho, M., Nanto-Salonen, K., Seppanen-Laakso, T., Parikka, V., Katajamaa, M., Hekkala, A., Mattila, I., Keskinen, P., et al. (2008). Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205, 2975-2984.
77. Padberg, I., Peter, E., Gonzalez-Maldonado, S., Witt, H., Mueller, M., Weis, T., Bethan, B., Liebenberg, V., Wiemer, J., Katus, H.A., et al. (2014). A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS One 9, e85082.
78. Palmer, N.D., Stevens, R.D., Antinozzi, P.A., Anderson, A., Bergman, R.N., Wagenknecht, L.E., Newgard, C.B., and Bowden, D.W. (2015). Metabolomic profile associated with insulin resistance and conversion to diabetes in the insulin resistance atherosclerosis study. J. Clin. Endocrinol. Metab 100, E463-468.
79. Pataky, Z., Armand, S., Muller-Pinget, S., Golay, A., and Allet, L. (2014). Effects of besity on functional capacity. Obesity (Silver Spring) 22, 56-62.
80. Pietiläinen, K.H., Sysi-Aho, M., Rissanen, A., Seppänen-Laakso, T., Yki-Järvinen, H., Kaprio, J., and Oresic, M. (2007). Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study. PLoS One 2, e218.
81. Randle, P.J. (1998). Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14, 263-283.
82. Rhee, E.P., Cheng, S., Larson, M.G., Walford, G.A., Lewis, G.D., McCabe, E., Yang, E., Farrell, L., Fox, C.S., O'Donnell, C.J., et al. (2011). Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121, 1402-1411.
83. Sadanala, K.C., Jeongae, L., Bong Chul, C., and Man Ho, C. (2012). Targeted metabolite profiling: sample preparation techniques for GC-MS-based steroid analysis. Mass Spectrometry Lett. 3, 4-9.
84. Salek, R.M., Maguire, M.L., Bentley, E., Rubtsov, D.V., Hough, T., Cheeseman, M., Nunez, D., Sweatman, B.C., Haselden, J.N., Cox, R.D., et al. (2007). A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol. Genomics 29, 99-108.
85. Samad, F., Hester, K.D., Yang, G., Hannun, Y.A., and Bielawski, J. (2006). Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55, 2579-2587.
86. Saris, W.H. (2003). Sugars, energy metabolism, and body weight control. Am. J. Clin. Nutr. 78, 850S-857S.
87. Scarfe, G.B., Wright, B., Clayton, E., Taylor, S., Wilson, I., Lindon, J.C., and Nicholson, J.K. (1998). 19F-NMR and directly coupled HPLC-NMR-MS investigations into the metabolism of 2-bromo-4-trifluoromethylaniline in rat: a urinary excretion balance study without the use of radiolabelling. Xenobiotica 28, 373-388.
88. Sellers, M.B., Tricoci, P., and Harrington, R.A. (2009). A new generation of antiplatelet agents. Curr. Opin. Cardiol. 24, 307-312.
89. Sener, A., and Malaisse, W.J. (1980). L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288, 187-189.
90. Shah, S.H., Kraus, W.E., and Newgard, C.B. (2012). Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126, 1110-1120.
91. Shaham, O., Wei, R., Wang, T.J., Ricciardi, C., Lewis, G.D., Vasan, R.S., Carr, S.A., Thadhani, R., Gerszten, R.E., and Mootha, V.K. (2008). Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 4, 214.
92. She, P., Reid, T.M., and Bronson, S.K. (2007). Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 6, 181-194.
93. Sims, E.A., Danforth, E., Jr., Horton, E.S., Bray, G.A., Glennon, J.A., and Salans, L.B. (1973). Endocrine and metabolic effects of experimental obesity in man. Recent Prog. Horm. Res. 29, 457-496.
94. Siri-Tarino, P.W., Sun, Q., Hu, F.B., and Krauss, R.M. (2010). Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 91, 502-509.
95. Smith, P.A., Sakura, H., Coles, B., Gummerson, N., Proks, P., and Ashcroft, F.M. (1997). Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells. J. Physiol. 499 (Pt 3), 625-635.
96. Sparks, D.L., and Chatterjee, C. (2012). Purinergic signaling, dyslipidemia and inflammatory disease. Cell Physiol. Biochem. 30, 1333-1339.
97. Sparks, D.L., Doelle, H., and Chatterjee, C. (2014). Circulating nucleotide levels in health and disease. Receptors Clin. Invest. 1, e344.
98. Stolar, M.W. (1988). Atherosclerosis in diabetes: the role of hyperinsulinemia. Metabolism 37, 1-9.
99. Stumvoll, M., Goldstein, B.J., and van Haeften, T.W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346.
100. Suhre, K., Meisinger, C., Doring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M.V., Gall, W.E., Weinberger, K.M., et al. (2010). Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5, e13953.
101. Tremblay, F., Lavigne, C., Jacques, H., and Marette, A. (2007). Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu. Rev. Nutr. 27, 293-310.
102. Um, S.H., D'Alessio, D., and Thomas, G. (2006). Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3, 393-402.
103. van Kampen, J.J., Burgers, P.C., de Groot, R., Gruters, R.A., and Luider, T.M. (2011). Biomedical application of MALDI mass spectrometry for small-molecule analysis. Mass Spectrom Rev. 30, 101-120.
104. Villarreal-Pérez, J.Z., Villarreal-Martínez, J.Z., Lavalle-González, F.J., Torres-Sepúlveda, M.d.R., Ruiz-Herrera, C., Cerda-Flores, R.M., Castillo-García, E.R., Rodríguez-Sánchez, I.P., and Villarreal, L.E.M.d. (2014). Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus. Diabetol. Metab. Syndr. 6, 129-136.
105. Vinayavekhin, N., Homan, E.A., and Saghatelian, A. (2010). Exploring disease through metabolomics. ACS Chem. Biol. 5, 91-103.
106. Wahl, S., Yu, Z., Kleber, M., Singmann, P., Holzapfel, C., He, Y., Mittelstrass, K., Polonikov, A., Prehn, C., Römisch-Margl, W., et al. (2012). Childhood obesity is associated with changes in the serum metabolite profile. Obes. Facts 5, 660-670.
107. Wang, T.J., Larson, M.G., Vasan, R.S., Cheng, S., Rhee, E.P., McCabe, E., Lewis, G.D., Fox, C.S., Jacques, P.F., Fernandez, C., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453.
108. Wang-Sattler, R., Yu, Z., Herder, C., Messias, A.C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012). Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 8, 615-625.
109. Warram, J.H., Martin, B.C., Krolewski, A.S., Soeldner, J.S., and Kahn, C.R. (1990). Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parent. Ann. Intern. Med. 113, 909-915
110. Wenk, M.R. (2005). The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594-610.
111. Williams, R., Lenz, E.M., Wilson, A.J., Granger, J., Wilson, I.D., Major, H., Stumpf, C., and Plumb, R. (2006). A multi-analytical platform approach to the metabonomic analysis of plasma fromnormal and Zucker (fa/fa) obese rats. Mol. Biosyst. 2, 174-183.
112. Wylie-Rosett, J., and Davis, N.J. (2009). Low-carbohydrate diets: an update on current research. Curr. Diab. Rep. 9, 396-404.
113. Xie, B., Waters, M.J., and Schirra, H.J. (2012). Investigating potential mechanisms of obesity by metabolomics. J. Biomed. Biotechnol. 2012, 805683.
114. Xu, F., Tavintharan, S., Sum, C.F., Woon, K., Lim, S.C., and Ong, C.N. (2013). Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. J. Clin. Endocrinol. Metab. 98, E1060-1065.
115. Yamamoto, Y., Hirose, H., Saito, I., Tomita, M., Taniyama, M., Matsubara, K., Okazaki, Y., Ishii, T., Nishikai, K., and Saruta, T. (2002). Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoproteincholesterol, independent of body mass index, in the Japanese population. Clin. Sci. 103, 137-142.
116. Yan, Y., Wang, Q., Li, W., Zhao, Z., Yuan, X., Huang, Y., and Duan, Y. (2014). Discovery of potential biomarkers in exhaled breath for diagnosis of type 2 diabetes mellitus based on GC-MS with metabolomics. RSC Adv. 4, 25430-25439.
117. Yi, L.Z.., He, J., Liang, Y.Z., Yuan, D.L., and Chau, F.T. (2006). Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA. FEBS Lett. 580, 6837-6845.
118. Zeisel, S.H. (2000). Choline: an essential nutrient for humans. Nutrition 16, 669-671.
119. Zeng, M., Liang, Y., Li, H., Wang, M., Wang, B., Chen, X., Zhou, N., Cao, D., and Wu, J. (2010). Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjunction with multivariate statistical analysis. J Pharm Biomed Anal 52, 265-272.
120. Zeng, M., Liang, Y., Li, H., Wang, B., and Chen, X. (2011). A metabolic profiling strategy for biomarker screening by GC-MS combined with multivariate resolution method and Monte Carlo PLS-DA. Analytical Methods 3, 438-445.
121. Zhang, A., Sun, H., Wang, P., Han, Y., and Wang, X. (2012). Modern analytical techniques in metabolomics analysis. Analyst 137, 293-300.
122. Zhang, A.H., Sun, H., Qiu, S., and Wang, X.J. (2013). Recent highlights of metabolomics in chinese medicine syndrome research. Evid Based Complement Alternat Med 2013, 402159.
123. Zhao, X., Fritsche, J., Wang, J., Chen, J., Rittig, K., Schmitt-Kopplin, P., Fritsche, A., Haring, H.U., Schleicher, E.D., Xu, G., et al. (2010). Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6, 362-374.